Q3 2025 Chemed Corp Earnings Call Transcript
Key Points
- VITAS Healthcare Corporation, a subsidiary of Chemed Corp (CHE), reported a 5.6% increase in admissions compared to the same period in 2024.
- Roto-Rooter residential plumbing revenue increased by 8.2% in the third quarter of 2025 compared to the same period in 2024.
- Chemed Corp (CHE) successfully mitigated the Florida Medicare Cap billing limitation, coming in slightly better than expected with an $18.9 million limitation.
- The new Pinellas County location for VITAS is on track to open in early November, and the Marion County program has grown significantly since its opening.
- Chemed Corp (CHE) reaffirmed its guidance for the year, indicating confidence in meeting its financial targets despite challenges.
- Roto-Rooter revenue from independent contractors declined by 4.7% in the third quarter of 2025 compared to the same period in 2024.
- Roto-Rooter's adjusted EBITDA decreased by 12.4% compared to the prior year quarter, with margins below long-term expectations.
- The shift from unpaid to paid leads at Roto-Rooter led to a $3.6 million increase in SG&A costs, impacting EBITDA margins.
- VITAS experienced a decline in high acuity days-of-care, negatively impacting revenue growth by 121 basis points.
- Chemed Corp (CHE) faced challenges with the competitive dynamics in the Roto-Rooter segment, leading to increased marketing costs and margin pressure.
Good morning, and thank you for standing by. Welcome to the Chemed Corporation third quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Holley Schmidt, Assistant Controller. Please go ahead.
Good morning. Our conference call this morning will review the financial results for the third quarter of 2025 ended September 30, 2025. Before we begin, let me remind you that the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 apply to this conference call. During the course of this call, the company will make various remarks concerning management's expectations, predictions, plans and prospects that constitute forward-looking statements.
Actual results may differ materially from those projected by these forward-looking statements as a result of a variety of factors, including those identified in the company's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
